Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. | Available online http content 7 3 113 Correction Correction Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Xenofon Baraliakos1 Joachim Listing2 Jan Brandt1 Angela Zink2 Rieke Alten3 Gerd Burmester4 Erika Gromnica-Ihle5 Herbert Kellner6 Matthias Schneider7 Helmut Sorensen8 Henning Zeidler9 Martin Rudwaleit10 Joachim Sieper10 and Juergen Braun1 1 Rheumazentrum Ruhrgebiet Herne Ruhr University Bochum Germany 2German Rheumatism Research Center Berlin Germany 3Schlosspark Clinic Berlin Germany 4Charité University Medicine Berlin Campus Mitte Germany 5Berlin-Buch Hospital Berlin Germany 6Ludwig-Maximilians-University Munich Germany 7Heinrich-Heine-University Dusseldorf Germany 8 Private Praxis Berlin Germany 9Medical University of Hannover Hanover Germany 10Charité Medical University of Berlin Campus Benjamin Franklin Department of Rheumatology Germany Corresponding author Juergen Braun Published 23 March 2005 This article is online at http content 7 3 113 2005 BioMed Central Ltd After publication of this work 1 we noted that we inadvertently failed to include the complete list of all coauthors. The full list of authors has now been added and the Authors contributions and Competing interests section modified accordingly. Competing interests Dr Braun and Dr Sieper have held consultancies and received research honoraria speaker s honoraria and grants research support from Centocor Schering-Plough Essex Pharma Wyeth and Abbott. Dr Zeidler has received speaker s honoraria from Essex Pharma. Dr Burmester has held consultancies for Centocor Essex Pharma Wyeth and Abbott has received honoraria from Centocor Essex Pharma Wyeth and Abbott has been a member of a speaker s bureau for Centocor Essex Pharma Wyeth and Abbott and has received grants research support from Centocor Essex Pharma and .
